Colin Carrie on Questions on the Order Paper

With regard to Health Canada’s approval of the Pfizer COVID-19 vaccines, broken down by each vaccine: (a) which pharmacokinetic studies were considered as part of the approval process, and what were the results of each study; (b) if there were no pharmacokinetic studies available for review, why did Health Canada not require such studies; (c) were genotoxicity studies reviewed in the approval process, and, if not, why not; (d) if the answer to (c) is affirmative, what are the details, including who conducted the studies and what were the findings; (e) were carcinogenicity studies reviewed in the approval process, and, if not, why not; (f) if the answer to (e) is affirmative, what are the details, including who conducted the studies and what were the findings; (g) what are the details of all safety, toxicology, developmental, and reproductive studies which were conducted on humans prior to the vaccine being approved, including, for each, (i) who conducted the study, (ii) the methodology, (iii) the findings; (h) were the vaccines tested in regards to transmission, and, if so, what were the results; and (i) for each study in (a) through (h) what is the website location where the raw data and findings can be viewed by the public?